ReviewHistology and histopathology2025
The role of neutrophils and their immunosuppressive effects on prostate cancer.
Review in Histology and histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [A risk prediction model for prognosis and immunotherapy response in prostate cancer patients based on immunosuppressive neutrophil Neu_2 subsets].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Over the past decade, there has been a significant increase in the incidence of prostate cancer on a global scale, establishing it as the second most prevalent malignant tumor among European and American males. Neutrophils are myeloid immune cells that constitute a crucial proportion of inflammatory cells within the human circulatory system and actively contribute to the composition of the prostate tumor microenvironment (TME). Recent investigations have revealed that neutrophils are influenced by the surrounding tumor environment and possess a dual capacity to either promote or suppress cancer within the TME. Nevertheless, the precise mechanisms of neutrophils in prostate cancer remain inadequately elucidated. In this review, we aimed to comprehensively outline the character of neutrophils in the development and progression of prostate cancer while also exploring the clinical prognostic significance of the neutrophil-to-lymphocyte ratio (NLR).
Indexed as
Identifiers
40040555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.